Expertise in
22
conditions

Chao Y. Cheng

168 Changhai Road, 
Yangpu, CN 
Expertise in
22
conditions
168 Changhai Road, 
Yangpu, CN 

Overview

Chao Cheng practices practicing medicine in Yangpu, China.

Mr. Cheng is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Lung Cancer, Inflammatory Myofibroblastic Tumor, Reconstructive Urology Surgery, and Thymectomy.

He is actively involved in clinical research, co-authoring 835 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

168 Changhai Road, Yangpu, 200433, China
Other Locations
366 Taihu Road, Taizhou, China
Union Hospital, Wuhan, 430022, China
397 Jixi Road, Hefei, 230022, China
58 Zhongshan 2nd Road, Guangzhou, 510080, China
2 Zheshan West Road, Wuhu, 241001, China
No. 299 Qing Yang Road, Wuxi, 214023, China
No.1 Xinsi Road, Xi'an, 710038, China
26 Shengli Street, Wuhan, 430030, China
118 North KangFu Road, Yiyang, 413000, China
No.168 Changhai Road, Yangpu, 200433, China
218#Ji Xi Road, Hefei, 230032, China
#79 Qingchun Road, Hangzhou, 310003, China
388 Gaoxin 2nd Road, Wuhan, 430075, China
Block 10, No. 168 In Changhai Road, Yangpu, 200433, China
299 Qingyang Road, Wuxi, 214023, China
28 Fuxing Road, Beijing, 100853, China
168 Chang Hai Road, Shanghai, 200433, China
No. 87 Xiangya Road, Changsha, 410008, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Multicentre, Prospective, Open Clinical Study of Postoperative ctDNA Dynamic Monitoring and Its Role of Prognosis in Patients With Stage I Non-small Cell Lung Cancer (NSCLC) Using Secondary Gene Sequencing (NGS)
Multicentre, Prospective, Open Clinical Study of Postoperative ctDNA Dynamic Monitoring and Its Role of Prognosis in Patients With Stage I Non-small Cell Lung Cancer (NSCLC) Using Secondary Gene Sequencing (NGS)
Enrollment Status: Completed
Publish Date: September 04, 2024
Intervention Type: Genetic

835 Total Publications

Advances in minimally invasive surgical techniques for esophageal cancer
Advances in minimally invasive surgical techniques for esophageal cancer
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: July 27, 2026

Frequently Asked Questions about Chao Y. Cheng

Is Chao Y. Cheng a top-rated expert for Lung Adenocarcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Chao Y. Cheng is classified as an Distinguished expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Chao Y. Cheng participate in research or clinical trials?

Yes. Chao Y. Cheng has published 835 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Chao Y. Cheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cheng's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 129 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile